Rezolve AI PLC美股招股说明书(2025-05-27版)

Up to 20,249,283 Ordinary Shares(for resale) This prospectus relates to the resale by certain selling security holders named herein (the “Selling Holders”) of up to 20,249,283Ordinary Shares, consisting of (i) up to 2,760,848 Ordinary Shares issued in connection with the Bluedot Acquisition (as definedherein); (ii) up to 3,999,145 Ordinary Shares issued in connection with the GroupBy Acquisition (iii) up to 12,300,000 OrdinaryShares issuable to Western Alliance Bank ("WAB") in connection with the WAB Subscription Letter (as defined herein); (iv) up to89,290 Ordinary Shares issuable to Roth Capital Partners, LLC as transaction-based compensation for the performance of advisoryservices rendered to the Company in connection with the Business Combination (as defined herein); (v) up to 300,000 OrdinaryShares issued to Radio Group Holding GmbH and certain other holders in connection with the settlement of an agreement; and (vi)up to 800,000 Ordinary Shares issuable to DBLP in connection with the DBLP Settlement Agreement (as defined herein). Certain of the Selling Holders may have acquired the securities registered hereunder at prices substantially below current marketprices and may therefore have incentive to sell their securities in this offering. Public securityholders who purchased their Rezolvesecurities at higher prices than the Selling Holders may experience lower rates of return (if any) than the Selling Holders, due todifferences in purchase prices and the potential trading price at which they may be able to sell (see “Risk Factors —Risks Relatedto Ownership of Ordinary Shares and Rezolve Operating as a Public Company —The trading price of Ordinary Shares could bevolatile, and the value of Ordinary Shares may decline.”). The Ordinary Shares being offered for resale pursuant to this prospectusby the Selling Holders represent approximately 8.23% of the outstanding Ordinary Shares as of the date of this prospectus. Giventhe substantial number of Ordinary Shares being registered for potential resale by Selling Holders pursuant to this prospectus, thesale of shares by the Selling Holders, or the perception in the market that the Selling Securityholders of a large number of sharesintend to sell shares, could increase the volatility of the market price of the Ordinary Shares or result in a significant decline in thepublic trading price of the Ordinary Shares. This prospectus provides you with a general description of such securities and the general manner in which the Selling Holdersmay offer or sell the securities. More specific terms of any securities that the Selling Holders may offer or sell may be provided in aprospectus supplement that describes, among other things, the specific amounts and prices of the securities being offered and theterms of the offering. The prospectus supplement may also add, update or change information contained in this prospectus. We will not receive any proceeds from the sale of the Ordinary Shares by the Selling Holders pursuant to this prospectus. We willpay the expenses in connection with the preparation of this prospectus and associated with the sale of securities pursuant to thisprospectus. Our registration of the securities covered by this prospectus does not mean that either the Selling Holders will issue,offer or sell, as applicable, any of the securities. The Selling Holders may offer and sell the securities covered by this prospectus ina number of different ways and at varying prices. We provide more information in the section entitled“Plan of Distribution.” You should read this prospectus and any prospectus supplement or amendment carefully before you invest in our securities. The Ordinary Shares and the Public Warrants are traded on The Nasdaq Stock Market LLC (“Nasdaq”) under the symbols“RZLV." On May 22, 2025, the closing price of the Ordinary Shares was $2.19 per share. Given the substantial amount of redemptions in connection with the Business Combination, and the relative lack of liquidity in ourstock, sales of the Ordinary Shares under the registration statement of which this prospectus is a part could result in a significantdecline in the market price of our securities. Investing in our securities involves risks. See“Risk Factors”beginning on page 10 and in any applicable prospectussupplement. None of the U.S. Securities and Exchange Commission or any state securities commission has approved or disapproved ofthe securities or determined if this prospectus is accurate or adequate. Any representation to the contrary is a criminaloffense. The date of this prospectus is May 23, 2025. TABLE OF CONTENTS ABOUT THIS PROSPECTUSiiTRADEMARKSiiiMARKET AND INDUSTRY DATAiiiSELECTED DEFINITIONSivCAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSvPROSPECTUS SUMMARY1THE OFFERING7RISK FACTORS8USE OF PROCEEDS30DIVIDEND POLICY30MARKET PRICE OF OUR SECURITIES30UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION31MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCI